SMi�s 3D Cell Culture Announces Key Industry Speakers and Agenda Released

London, United Kingdom, November 09, 2018 –(PR.com)– Proudly sponsored by InoCure & TEDD Competence Centre

Proud to announce the Co-Chairs for the conference Nicola Valeri, Gastrointestinal Cancer Biology and Genomics Team Leader, The Institute of Cancer Research and Stefan Przyborski, Professor of Cell Technology, University of Durham; Nicola Valeri, Gastrointestinal Cancer Biology and Genomics Team Leader, The Institute of Cancer Research

Dr. Valeri is a Clinician/Scientist working to discover novel therapeutic targets and novel biomarkers for gastrointestinal cancers. He leads the Gastrointestinal Cancer Biology and Genomics Team within the Centre for Molecular Pathology at the Institute of Cancer Research in London. He is also an Academic Consultant in Medical Oncology in the Gastrointestinal Cancer Unit at the Royal Marsden Hospital.

Stefan Przyborski, Professor of Cell Technology, University of Durham
Professor Przyborski holds an academic position as Professor in Cell Technology at Durham University. He has over 25 years experience in cell biology with specific interests in cell culture technology, neuroscience and stem cell research. In recent years he has developed a multi-disciplinary approach through collaborative projects with physical scientists to develop novel ways of solving biological problems.

SMi is also proud to announce that the U.S. Food and Drug Administration will be joining this year, at the conference will be Bill Mattes, Director, Division of Systems Biology, USA FDA:

Dr. Mattes is the Director of the Division of Systems Biology, part of the FDA’s National Center for Toxicological Research. He has been an independent consultant as well as Director of Toxicology at the Critical Path Institute where he developed and directed the Predictive Safety Testing Consortium (PSTC), a collaboration of the world’s major pharmaceutical companies, with FDA and EMEA advisors. This work resulted in the establishment of a formal process of FDA/EMA biomarker qualification. Dr. Mattes also developed the COPD Biomarkers Qualification Consortium.

Key Expert Speakers include:
Asli Akidil, Cell and Molecular Scientist, AstraZeneca
Gary Allenby, Business Development Director and Chief Scientific Officer, Aurelia Biosciences
Jason Ekert, Head of Complex In Vitro Models, GSK
Philip Hewitt, UK and Eurotox Registered Toxicologist, Head of Early Investigative Technology, Merck
Stefan Kustermann, Lab Head, Investigative Safety, Roche
Veronique Barban, Expert Virology, Research and Nonclinical Safety Department, Sanofi Pasteur

To view the full speaker line-up and 2-day agenda visit the website:
www.3d-cellculture.com/PR1

The conference also has an interactive half day pre conference workshop, which provide extra value to the 3D Cell Culture conference, taking place on Tuesday 19th February 2019 at the same venue.

Morning Workshop A: 3D you can see – planar 2D spheroid arrays for histology.

Workshop Leaders: Dr. Patrick Kugelmeier, Founder, Director of Science, Kugelmeiers & Dr. Michael Raghunath, Professor for Biochemistry, Protein Technology and Tissue Engineering, Zurich University of Applied Sciences

If you are interested in participating and attending the conference, you can register at www.3d-cellculture.com/PR1 and save £200.

Interested in sponsoring, exhibiting or speaking at this event?

Contact Alia Malick, Director, on +44 (0) 20 827 6168 or email amalick@smi-online.co.uk

For media enquiries, contact Simi Sapal on +44 (0) 20 7827 6000 or ssapal@smi-online.co.uk

3D Cell Culture Conference 2019
20 – 21 February 2019
Copthorne Tara Hotel, London, UK
www.3d-cellculture.com/PR1

Follow us @SMiPharm
#SMi3DCellCulture

About SMi Group: Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward-thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk